AVAH - Aveanna Healthcare Holdings Inc. Stock Price, Fair Value and News

2.20USD0.00 (0.00%)Market Closed

Market Summary

USD2.200.00

Market Closed

0.00%

AVAH Stock Price

View Fullscreen

AVAH RSI Chart

AVAH Valuation

Market Cap

423.2M

Price/Earnings (Trailing)

-3.15

Price/Sales (Trailing)

0.22

EV/EBITDA

13.53

Price/Free Cashflow

18.67

AVAH Price/Sales (Trailing)

AVAH Profitability

EBT Margin

-7.33%

Return on Equity

103.82%

Return on Assets

-8.34%

Free Cashflow Yield

5.36%

AVAH Fundamentals

AVAH Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

6.14%

Rev. Growth (Qtr)

0.17%

AVAH Earnings

Earnings (TTM)

-134.5M

Earnings Growth (Yr)

89.18%

Earnings Growth (Qtr)

74.86%

Breaking Down AVAH Revenue

Last 7 days

-3.9%

Last 30 days

-10.2%

Last 90 days

-7.6%

Trailing 12 Months

88.0%

How does AVAH drawdown profile look like?

AVAH Financial Health

Current Ratio

0.89

AVAH Investor Care

Shares Dilution (1Y)

2.59%

Diluted EPS (TTM)

-0.72

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.8B	1.8B	1.9B	1.9B
2022	1.7B	1.7B	1.8B	1.8B
2021	1.6B	1.6B	1.7B	1.7B
2020	1.4B	1.4B	1.5B	1.5B
2019	0	0	0	1.4B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Aveanna Healthcare Holdings Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 21, 2024	windley rodney d	acquired	-	-	62,241	-
Feb 21, 2024	buckhalter matthew	acquired	-	-	149,897	chief financial officer
Feb 21, 2024	rodgers steven e	acquired	-	-	53,942	-
Feb 21, 2024	schwartz erica	acquired	-	-	53,942	-
Feb 21, 2024	reisz edwin c.	acquired	-	-	124,482	chief administrative officer
Feb 21, 2024	retchin sheldon m	acquired	-	-	53,942	-
Feb 21, 2024	ganzi victor f	acquired	-	-	53,942	-
Feb 21, 2024	stewart deborah	acquired	-	-	46,680	svp, chief accounting officer
Feb 21, 2024	cunningham patrick a.	acquired	-	-	43,568	chief compliance officer
Feb 21, 2024	zoretic richard c	acquired	-	-	53,942	-

Which funds bought or sold AVAH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	SIMPLEX TRADING, LLC	new	-	2,000	2,000	-%
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-11.83	-77,220	349,889	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-73.72	-11,000	3,000	-%
Apr 23, 2024	J.H. Whitney Equity Partners VII, LLC	unchanged	-	-9,244,620	121,153,000	100.00%
Apr 19, 2024	DENALI ADVISORS LLC	added	65.07	655	1,882	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	-	1,000	-%
Apr 18, 2024	WOLFF WIESE MAGANA LLC	unchanged	-	-57.00	747	-%
Apr 05, 2024	CWM, LLC	new	-	-	-	-%
Mar 11, 2024	VANGUARD GROUP INC	added	3.14	3,855,600	6,770,430	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	87.42	188,103	246,506	-%

Are Funds Buying or Selling AVAH?

Are funds buying AVAH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AVAH

No. of Funds

Unveiling Aveanna Healthcare Holdings Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	nut tree capital management, lp	6.5%	12,372,649	SC 13G
Feb 14, 2022	bcpe eagle investor, lp	44.3%	81,600,880	SC 13G
Feb 14, 2022	j.h. whitney vii, l.p.	8.54%	15,725,196	SC 13G

Recent SEC filings of Aveanna Healthcare Holdings Inc.

View All Filings

Date Filed	Form Type	Document
Apr 01, 2024	ARS	ARS
Apr 01, 2024	DEF 14A	DEF 14A
Apr 01, 2024	DEFA14A	DEFA14A
Mar 14, 2024	10-K	Annual Report
Mar 14, 2024	8-K	Current Report
Mar 14, 2024	S-8	Employee Benefits Plan
Mar 14, 2024	S-8	Employee Benefits Plan
Feb 23, 2024	4	Insider Trading
Feb 23, 2024	4	Insider Trading
Feb 23, 2024	4	Insider Trading

Peers (Alternatives to Aveanna Healthcare Holdings Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	456.6B	371.6B	0.44%	0.97%	20.4	1.23	14.64%	11.24%
CI	103.6B	195.3B	-2.45%	41.59%	19.29	0.53	8.17%	-20.79%
CVS	84.5B	357.8B	-15.42%	-8.05%	10.12	0.24	10.95%	93.52%
HCA	81.1B	65.0B	-7.58%	8.53%	15.47	1.25	7.86%	-7.11%
CNC	39.7B	155.5B	-5.58%	8.00%	14.51	0.26	6.34%	84.42%
DVA	11.7B	12.1B	-2.44%	51.70%	16.93	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.81%	13.72%	16.01	0.8	6.59%	6.24%
MID-CAP
CHE	8.5B	2.3B	-13.21%	2.71%	31.02	3.73	6.06%	9.17%
ACHC	6.8B	2.9B	-6.00%	1.13%	-313.66	2.32	12.20%	-107.93%
AMN	2.2B	3.8B	-7.09%	-33.84%	10.27	0.57	-27.73%	-52.50%
AMEH	2.0B	1.4B	-10.80%	1.66%	33.48	1.47	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.94%	-17.15%	24.52	1.45	11.31%	35.83%
BKD	1.3B	3.0B	5.61%	63.76%	-6.97	0.44	6.74%	20.73%
BEAT	52.7M	-	-9.91%	-0.99%	-3.6	-	-	-12.94%
AMS	20.1M	21.3M	17.84%	15.27%	37.65	0.94	8.00%	-62.25%

Aveanna Healthcare Holdings Inc. News

Latest updates

Aveanna Healthcare Holdings Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	0.2%	478,841,000	478,010,000	471,945,000	466,413,000	451,147,000	443,009,000	442,955,000	450,534,000	414,070,000	411,276,000	436,112,000	417,160,000	422,302,000	366,003,000	351,577,000	355,223,000	-
S&GA Expenses	-4.4%	87,011,000	91,004,000	91,255,000	91,708,000	89,947,000	89,542,000	88,998,000	88,743,000	73,919,000	76,370,000	77,720,000	69,372,000	66,491,000	59,641,000	55,120,000	59,694,000	-
EBITDA Margin	115.0%	0.01	-0.10	-0.04	-0.32	-0.30	-0.25	-0.27	0.00	-0.01	0.06	0.06	0.01	0.03	-	-	-	-
Interest Expenses	0.3%	39,704,000	39,599,000	37,985,000	35,958,000	33,975,000	28,462,000	22,919,000	22,364,000	15,137,000	12,106,000	19,262,000	22,425,000	24,011,000	19,065,000	18,844,000	21,063,000	-
Income Taxes	-1073.9%	-5,843,500	600,000	-810,000	1,566,000	-1,365,500	-2,669,000	-344,000	2,600,000	4,074,000	-1,100,000	179,000	309,000	2,401,000	-471,000	2,255,000	1,131,000	-
Earnings Before Taxes	69.0%	-31,595,000	-101,758,000	24,789,000	-30,432,000	-239,143,000	21,629,000	-474,231,000	27,931,000	-122,112,000	990,000	1,439,000	6,107,000	-7,331,000	-7,873,000	-75,298,000	38,768,000	-
EBT Margin	60.5%	-0.07	-0.19	-0.12	-0.40	-0.37	-0.31	-0.33	-0.05	-0.07	0.00	0.00	-0.05	-0.03	-	-	-	-
Net Income	74.9%	-25,736,000	-102,389,000	25,599,000	-31,998,000	-237,779,000	24,298,000	-473,887,000	25,334,000	-126,192,000	2,090,000	1,260,000	5,798,000	-9,732,000	-7,402,000	-77,553,000	37,637,000	-
Net Income Margin	61.8%	-0.07	-0.19	-0.12	-0.40	-0.37	-0.31	-0.33	-0.06	-0.07	0.00	-0.01	-0.06	-0.04	-	-	-	-
Free Cashflow	-110.5%	-3,005,000	28,700,000	-13,333,000	4,680,000	-43,051,000	18,376,000	-21,882,000	-13,460,000	-39,182,000	31,581,000	15,877,000	-35,576,000	-4,580,000	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet													(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-2.5%	1,613	1,655	1,741	1,731	1,712	1,973	1,909	2,376	2,334	1,956	1,960	1,798	1,844
Current Assets	-1.1%	315	318	301	308	270	312	293	286	279	343	346	293	341
Cash Equivalents	-9.0%	44.00	48.00	28.00	34.00	19.00	64.00	17.00	17.00	30.00	122	107	67.00	137
Net PPE	-6.6%	21.00	22.00	20.00	21.00	23.00	25.00	27.00	29.00	31.00	32.00	32.00	32.00	33.00
Goodwill	0%	1,055	1,055	1,160	1,160	1,160	1,368	1,367	1,837	1,836	1,420	1,419	1.00	1,316
Liabilities	-1.0%	1,740	1,758	1,746	1,765	1,716	1,743	1,707	1,708	1,696	1,199	1,210	1,524	1,577
Current Liabilities	-2.6%	355	364	356	376	326	352	361	368	345	220	220	207	260
Shareholder's Equity	-Infinity%	-129	-	-	-	-6.31	228	200	666	636	754	748	272	265
Retained Earnings	-1.9%	-1,371	-1,345	-1,243	-1,268	-1,236	-998	-1,023	-549	-574	-448	-450	-451	-457
Additional Paid-In Capital	0.2%	1,240	1,238	1,234	1,231	1,229	1,225	1,222	1,213	1,209	1,201	1,197	722	721
Shares Outstanding	0%	191	191	190	189	189	185	185	185	185	185	157	142	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	-110.5%	-3,005	28,700	-10,518	7,495	-40,236	21,191	-19,881	-9,476	-33,538	35,809	19,290	-32,911	-1,499	41,532	32,532	44,053	-
Share Based Compensation	-41.1%	3,014	5,116	2,585	2,442	1,785	3,512	5,781	4,815	4,283	4,262	5,168	712	1,099	436	1,422	318	-
Cashflow From Investing	-39.1%	-1,568	-1,127	-1,299	-4,800	-3,199	-3,636	-1,813	-16,643	-568,323	-4,925	-105,418	-3,165	-132,043	-51,021	-4,153	-6,327	-
Cashflow From Financing	103.0%	221	-7,291	5,396	12,521	-1,029	28,663	21,718	13,068	510,643	-15,725	125,572	-34,164	-1,375	195,833	1,505	14,981	-

AVAH Income Statement

2023-12-30

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2022	Jul. 02, 2022	Dec. 30, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue			$ 1,895,209	$ 1,787,645
Cost of revenue, excluding depreciation and amortization			1,299,777	1,234,418
Branch and regional administrative expenses			360,978	357,230
Corporate expenses			113,034	137,864
Goodwill impairment	$ 205,100	$ 470,200	105,136	675,346
Depreciation and amortization			13,778	21,313
Acquisition-related costs			466	99
Other operating (income) expense			(6,032)	3,651
Operating income (loss)			8,072	(642,276)
Interest income			327	679
Interest expense			(153,246)	(107,720)
Other income			5,851	85,503
Loss before income taxes			(138,996)	(663,814)
Income tax benefit			4,472	1,780
Net loss			$ (134,524)	$ (662,034)
Net loss per share:
Net loss per share, basic			$ (0.71)	$ (3.57)
Net loss per share, diluted			$ (0.71)	$ (3.57)
Weighted average shares of common stock outstanding, basic			189,956	185,553
Weighted average shares of common stock outstanding, diluted			189,956	185,553

AVAH Balance Sheet

2023-12-30

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 43,942	$ 19,217
Patient accounts receivable	236,558	221,237
Receivables under insured programs	9,250	4,395
Prepaid expenses	15,684	15,089
Other current assets	9,452	9,813
Total current assets	314,886	269,751
Property and equipment, net	20,548	22,752
Operating lease right of use assets	49,499	54,601
Goodwill	1,054,552	1,159,688
Intangible assets, net	94,010	95,863
Receivables under insured programs	21,315	22,865
Other long-term assets	58,175	86,240
Total assets	1,612,985	1,711,760
Current liabilities:
Accounts payable and other accrued liabilities	30,130	44,624
Accrued payroll and employee benefits	67,160	43,836
Current portion of insurance reserves - insured programs	9,250	4,395
Current portion of insurance reserves	20,918	27,531
Securitization obligations	155,000	140,000
Current portion of long-term obligations	9,200	9,200
Current portion of operating lease liabilities	14,881	13,070
Other current liabilities	48,219	43,841
Total current liabilities	354,758	326,497
Long-term obligations, less current portion	1,276,341	1,281,082
Long-term insurance reserves - insured programs	21,315	22,865
Long-term insurance reserves	40,290	35,470
Operating lease liabilities, less current portion	39,818	45,818
Deferred income taxes	4,859	3,844
Other long-term liabilities	3,039	359
Total liabilities	1,740,420	1,715,935
Commitments and contingencies (Note 13)
Deferred restricted stock units	2,135	2,135
Stockholders' deficit:
Preferred stock, $0.01 par value as of December 30, 2023 and December 31, 2022 5,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 190,733,153 and 188,859,165 issued and outstanding, respectively	1,907	1,888
Additional paid-in capital	1,239,757	1,228,512
Accumulated deficit	(1,371,234)	(1,236,710)
Total stockholders' deficit	(129,570)	(6,310)
Total liabilities, deferred restricted stock units, and stockholders' deficit	$ 1,612,985	$ 1,711,760

About Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

CEO	Mr. Jeffrey S. Shaner
WEBSITE	aveanna.com
INDUSTRY	Healthcare Plans
EMPLOYEES	33700

Aveanna Healthcare Holdings Inc. Frequently Asked Questions

What is the ticker symbol for Aveanna Healthcare Holdings Inc.? What does AVAH stand for in stocks?

AVAH is the stock ticker symbol of Aveanna Healthcare Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aveanna Healthcare Holdings Inc. (AVAH)?

As of Fri Apr 26 2024, market cap of Aveanna Healthcare Holdings Inc. is 423.23 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AVAH stock?

You can check AVAH's fair value in chart for subscribers.

What is the fair value of AVAH stock?

You can check AVAH's fair value in chart for subscribers. The fair value of Aveanna Healthcare Holdings Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aveanna Healthcare Holdings Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AVAH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aveanna Healthcare Holdings Inc. a good stock to buy?

The fair value guage provides a quick view whether AVAH is over valued or under valued. Whether Aveanna Healthcare Holdings Inc. is cheap or expensive depends on the assumptions which impact Aveanna Healthcare Holdings Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AVAH.

What is Aveanna Healthcare Holdings Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, AVAH's PE ratio (Price to Earnings) is -3.15 and Price to Sales (PS) ratio is 0.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVAH PE ratio will change depending on the future growth rate expectations of investors.